Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI).
Paolisso P, Belmonte M, Gallinoro E, Scarsini R, Bergamaschi L, Portolan L, Armillotta M, Esposito G, Moscarella E, Montalto C, de Oliveira EK, Angeli F, Orzalkiewicz M, Fabroni M, Galli V, Baydaroglu N, Di Lenarda F, Policastro P, Terrone C, Ausiello D, Vincelli G, Casenghi M, Scisciola L, Marfella R, Gragnano F, Conte E, Pellegrini D, Ielasi A, Andreini D, Oreglia JA, Calabrò P, Bartorelli AL, Palmerini T, Saia F, Ribichini F, Barbieri M, Vanderheyden M, Pizzi C, Barbato E.
Paolisso P, et al. Among authors: montalto c.
Cardiovasc Diabetol. 2025 May 21;24(1):221. doi: 10.1186/s12933-025-02773-x.
Cardiovasc Diabetol. 2025.
PMID: 40399991
Free PMC article.